Western blot analysis revealed that the expression levels of the protein MMP-9, MMP-2 and Vimentin in tumor tissues of YFTL treatment groups were noticeably lower than that in the MC group (Figure 4B,C). The gene discussed is MMP2; the disease is neoplasm.